Navigation Links
Tibotec Advances Global Clinical Research Program for TMC435 in HCV; Will Present Four Abstracts Evaluating Safety and Efficacy at EASL
Date:3/29/2011

CORK, Ireland, March 29, 2011 /PRNewswire/ -- Tibotec Pharmaceuticals announced today that four abstracts reporting research findings with TMC435, the company's investigational hepatitis C protease inhibitor, have been accepted for presentation at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL) in Berlin, Germany, March 30 to April 3, 2011.  

The four abstracts for TMC435 support Tibotec's continued efforts to advance its research and development program for the treatment of HCV.  TMC435 highlights at the meeting include one oral presentation and one late-breaker poster presentation:

  • Analysis of the predictive nature of IL28B genotype and pretreatment serum IP-10 in treatment-naive HCV patients from phase IIb PILLAR study on TMC435 administered with pegIFN/ribavirin
  • Results from interim 24 week data of the international phase IIb randomized, double-blind, placebo-controlled ASPIRE study on efficacy, tolerability, safety, and pharmacokinetics of TMC435 administered with pegIFN/ribavirin in treatment-experienced HCV patients

    • "Tibotec is committed to developing innovative new treatment options that may offer better treatment outcomes and that may decrease the duration of treatment for patients with chronic hepatitis C infection," said Brian Woodfall M.D., Vice President of Global Clinical Development at Tibotec. "The company's presence at this year's EASL meeting and the recent launch of the phase 3 clinical trial program for TMC435 reinforce the value of this investigational agent in our growing HCV pipeline."

    The titles of the abstracts and times for Tibotec's presentations on TMC435 appear below – full abstracts can also be accessed at www.easl.eu.

    Oral Presentation:

  • "Impact of IL28B genotype and pretreatment serum IP-10 in treatment-naive genotype-1 HCV patients treated with TMC435 i
    '/>"/>

    • SOURCE Tibotec Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3

    Related biology technology :

    1. According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists
    2. 3-D printing method advances electrically small antenna design
    3. SG Biofuels Advances Jatropha Biotech Platform with Application of Genetic Markers to Reference Genome
    4. Redpoint Advances Salt Enhancer Discovery Program
    5. Circassia Initiates Phase II Trials of Novel Grass and Ragweed Allergy Therapies and Advances Phase III Plans for cat Allergy T-Cell Vaccine
    6. Santaris Pharma A/S Advances miravirsen, the First microRNA-Targeted Drug to Enter Clinical Trials, Into Phase 2 to Treat Patients Infected With Hepatitis C Virus
    7. New treatment for rabies advances after successful phase 1 trial in India
    8. Reportlinker Adds Advances in Biopharmaceutical Technology in China
    9. New Advances in Understanding of Parasite Risk Showcased at CVBD World Forum
    10. MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio
    11. Fulton Project Advances to Phase 2 of Loan Guarantee Process
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... Dr. Sparano is Professor of Medicine and ... Albert Einstein College of Medicine and Associate Chairman of ... He is also Associate Director for Clinical Research ... Breast Cancer Working Group, a multidisciplinary group of physicians ... also serves as Vice Chair of the National Cancer ...
    (Date:5/17/2013)... in German . ... naked eye, you can see which branch a bird is ... branches through the telephoto lens for high-magnification images requires considerable ... looking to study proteins, the active biomolecules of cells. , ... Molecular Systems Biology, and her colleagues have now come up ...
    (Date:5/17/2013)... (PRWEB) May 17, 2013 •    First of ... Certified for sustainability ,     New facility will help ... , Syngenta unveiled its new crop ... the company’s RTP Innovation Center. The first of its ... to simulate any agricultural climate and precisely measure plant ...
    (Date:5/17/2013)... , May 17, 2013  Yongye International, Inc. ... a leading developer, manufacturer, and distributor of crop nutrient ... , today announced that, on May 16, 2013, ... of directors (the "Board of Directors") was provided a ... Hong Kong ) Limited ("Abax") to Full ...
    Breaking Biology Technology:Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4
    ... Human Genome,Sciences, Inc. (Nasdaq: HGSI ) announced ... Health Care Conference will be webcast and may be,accessed ... ), A member of Human Genome Sciences, senior ... Wednesday, November 28, 2007 at 10:00 am,Eastern Time., ...
    ... Nov. 26 The worldwide burn treatment market,experienced growth ... Wound,Care Markets, Volume II: Burns, a new report by ... ups and downs due to price,constraints, new technologies, and ... by 2011., Conventional, mature products continue to generate ...
    ... MEDxConnect(TM) System Provides Ability to Integrate with Multiple ... Physician ... Efficiency and Diagnostic Turnaround, CHICAGO, Nov. 26 ... technology for seamless connectivity and,interoperability between diagnostic acquisition devices, ...
    Cached Biology Technology:Bio-advancements Expected to Drive Burn Care Market Growth Up $700 Million 2E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market 2E-Rad Solutions Selects Compressus' Enterprise Systems Integration Technology to Fuel Entry Into Teleradiology Market 3
    (Date:5/18/2013)... Orlando, FL (May 18, 2013) Research presented ... for managing digestive health through diet and lifestyle. ... often plagued by reduced muscle strength, fatigue and ... even when patients are in remission. A randomized, ... time that vitamin D supplementation corresponded to significant ...
    (Date:5/17/2013)... Researchers at Rutgers, The State University of New Jersey, ... proprietary new formulation called Visikol TM that effectively ... be used in place of chloral hydrate, which is ... but which is tightly regulated by the Drug Enforcement ... , Clearing solutions, or clearing agents, are vital for ...
    (Date:5/17/2013)... The iCargo project (Intelligent Cargo in Efficient and Sustainable ... thanks to an improvement in the efficiency of intermodal ... assist decision making. It comprises 29 European organisations with ... management. It has a budget totalling 17,000,000 and a ... is working to specify and develop the semantic components ...
    Breaking Biology News(10 mins):Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3New logistics services that will cut energy consumption and CO2 emissions 2
    ... Researchers at Carnegie Mellon University have developed a ... of an important class of drugs that target a ... "Drugs that target GPCRs make up approximately 30 ... some of the most prescribed drugs," said Jonathan Jarvik, ...
    ... be the perfect sidekick for the real thing as ... single-atom-thick layers of hexagonal boron nitride (h-BN), the material ... Mechanical Engineering and Materials Science, are likely to find ... lab of Pulickel Ajayan, Rice,s Benjamin M. and Mary ...
    ... to publish his famous "double elephant folio" The Birds of ... birds and animals, created a drawing of a running grouse ... note. Although the artist mentions the drawing and the resulting ... has ever been able to locate or identify such an ...
    Cached Biology News:Carnegie Mellon researchers create fluorescent biosensor to aid in drug development 2'White graphene' to the rescue 2Discovered: Audubon's first engraving of a bird 2
    Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
    Experion HighSens chips are the microfluidic chips used to perform high-sensitivity RNA analysis (picogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to ru...
    ...
    ...
    Biology Products: